Retrospective Analysis of treatment data regarding efficiency, efficacy and safety of a non-rechargeable deep brain stimulation system in patients with movement disorders.

Retrospective Analysis of treatment data regarding efficiency, efficacy and safety of a non-rechargeable deep brain stimulation system in patients with movement disorders. - retroInfinity

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039518

Enrollment

Registered

2026-05-08

Start date

2026-05-07

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease, essential tremor, dystonia

Interventions

Group 1: Adult patients that received an Abbott Infinity deep brain stimulation system or neurostimulator for treatment of their movement disorder at Heidelberg University Hospital between 2016 and 20

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Implantation of an Abbott Infinity DBS system or neurostimulator to treat a movement disorder between 2016 and 2025.

Exclusion criteria

Exclusion criteria: Implantation of other DBS systems or neurostimulators.

Design outcomes

Primary

Measure	Time frame
Duration of neurostimulator battery life	—

Secondary

Measure	Time frame
Factors that influence neurostimulator battery life. Complication rate Energy consumption (Total Electrical Energy Delivered; TEED)	—

Countries

Germany

Contacts

Public ContactMartin Jakobs

Neurochirurgische Klinik, Universitätsklinikum Heidelberg

neurostimulation.nch@med.uni-heidelberg.de+49-6221-566307

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026